Alerts will be sent to your verified email
Verify Email
PAR
|
Par Drugs & Chem.
|
AG Ventures
|
Resonance Specialtie
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
16.79 % | 8.45 % | 14.83 % |
|
5yr average Equity Multiplier
|
1.28 | 1.44 | 1.22 |
|
5yr Average Asset Turnover Ratio
|
0.92 | 0.4 | 1.06 |
|
5yr Avg Net Profit Margin
|
14.32 % | 22.03 % | 10.72 % |
|
Price to Book
|
1.04 | 0.41 | 1.86 |
|
P/E
|
11.42 | 10.62 | 16.51 |
|
5yr Avg Cash Conversion Cycle
|
-12.24 Days | 26.6 Days | 111.92 Days |
|
Inventory Days
|
16.4 Days | 72.77 Days | 98.79 Days |
|
Days Receivable
|
48.97 Days | 22.55 Days | 83.71 Days |
|
Days Payable
|
90.62 Days | 80.97 Days | 91.05 Days |
|
5yr Average Interest Coverage Ratio
|
113.93 | 39.08 | 78.86 |
|
5yr Avg ROCE
|
20.52 % | 8.49 % | 19.79 % |
|
5yr Avg Operating Profit Margin
|
22.04 % | 21.6 % | 15.26 % |
|
5 yr average Debt to Equity
|
0.03 | 0.19 | 0.04 |
|
5yr CAGR Net Profit
|
2.85 % | -33.25 % | -8.99 % |
|
5yr Average Return on Assets
|
13.02 % | 5.78 % | 12.27 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.41 % | 51.76 % | 54.25 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.8 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -8.04 % | 0.0 |
|
Par Drugs & Chem.
|
AG Ventures
|
Resonance Specialtie
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Raw Material Breakup
|
Raw Material Breakup
|
-
|
-
|